000 01484 a2200457 4500
005 20250515100242.0
264 0 _c20080205
008 200802s 0 0 eng d
022 _a1744-8328
024 7 _a10.1586/14737140.7.12s.S51
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPytel, Peter
245 0 0 _aSpectrum of pediatric gliomas: implications for the development of future therapies.
_h[electronic resource]
260 _bExpert review of anticancer therapy
_cDec 2007
300 _aS51-60 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdolescent
650 0 4 _aAge Factors
650 0 4 _aAstrocytoma
_xmortality
650 0 4 _aBiopsy, Needle
650 0 4 _aBrain Neoplasms
_xmortality
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCombined Modality Therapy
650 0 4 _aEpendymoma
_xmortality
650 0 4 _aFemale
650 0 4 _aGlioblastoma
_xmortality
650 0 4 _aGlioma
_xmortality
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aNeurosurgical Procedures
_xmethods
650 0 4 _aPrognosis
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aRisk Assessment
650 0 4 _aSurvival Analysis
773 0 _tExpert review of anticancer therapy
_gvol. 7
_gno. 12 Suppl
_gp. S51-60
856 4 0 _uhttps://doi.org/10.1586/14737140.7.12s.S51
_zAvailable from publisher's website
999 _c17589698
_d17589698